A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

British Journal of Cancer, Published online: 29 January 2024; doi:10.1038/s41416-023-02436-2A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

https://www.nature.com/articles/s41416-023-02436-2

Source: British Journal of Cancer - January 29, 2024 Category: Cancer & Oncology Authors: Howard A. Burris Jordan Berlin Tobias Arkenau Gregory M. Cote Martijn P. Lolkema Jordi Ferrer-Playan Anup Kalapur Jayaprakasam Bolleddula Giuseppe Locatelli Thomas Goddemeier Ioannis Gounaris Johann de Bono Source Type: research